|Daily Range||$16.65 - $17.19|
|52-Week Range||$8.42 - $29.79|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||469,579|
|Current FY EPS||-$1.33|
Repros Therapeutics, Inc. (RPRX) Description
A biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. Website: http://www.reprosrx.com/
News & Commentary
Repros wins meeting with FDA for oral testosterone frontrunner Androxal after FDA concerns last month tanked shares
UPDATE: Piper Jaffray Initiates Coverage on Repros Therapeutics on a Cleaner Approach to Male Hypogonadism
Johnson & Johnson, Orexigen, Repros, and Auxilium could all make health care headlines today. Let’s see why.
NxStage Medical, Immunogen, and Repros Therapeutics make this week's most horrendous health-care performers.